Global Amyotrophic Lateral Sclerosis Industry (2020 to 2027) – The US Market is Estimated to be $100.6 Million – ResearchAndMarkets.com | Financial Buzz

Global Amyotrophic Lateral Sclerosis Industry (2020 to 2027) – The US Market is Estimated to be $100.6 Million – ResearchAndMarkets.com

The “Amyotrophic Lateral Sclerosis – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Amyotrophic Lateral Sclerosis estimated at US$339.2 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 19.2% over the period 2020-2027.

The U.S. Market is Estimated at $100.6 Million, While China is Forecast to Grow at 18.4% CAGR

The Amyotrophic Lateral Sclerosis market in the U.S. is estimated at US$100.6 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$199.1 Million by the year 2027 trailing a CAGR of 18.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.1% and 16.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.

Select Competitors (Total 31 Featured):

  • AB Science SA
  • Apotex, Inc.
  • Aquestive
  • Biogen, Inc.
  • Brainstorm Cell Therapeutics Inc.
  • Cytokinetics, Inc.
  • F. Hoffmann-La Roche AG
  • Genervon Biopharmaceuticals LLC
  • Ionis Pharmaceuticals, Inc.
  • Kringle Pharma Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Neuralstem, Inc.
  • Orion Corporation
  • Orphazyme A/S
  • Sanofi SA
  • Treeway BV
  • Valeant Pharmaceuticals International, Inc.
  • ViroMed Co., Ltd.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 31

For more information about this report visit https://www.researchandmarkets.com/r/ay1mka

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!